drugset
drugset / Trial / NCT04650542

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

NCT04650542 ↗

Phase 1 Completed 39 enrolled HUYABIO International, LLC.
NaSingle-groupOpen-labelTreatment

Summary

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

Timeline

Start
2021-02-21
Primary completion
2021-08-13
Completion
2021-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 20 mg —
Subject SULCARDINE Small molecule 350 mg Intravenous

Indications

No indication recorded.